The study, SURVIVE, compared Simdax, also known as levosimendan, with an older treatment called dobutamine.

FORBES: Abbott Heart Failure Drug Misses Goal

At five days, mortality in the levosimendan group was reduced by 27%.

FORBES: Abbott Heart Failure Drug Misses Goal

Abbott shares were down 3.9% in morning trading on mixed results for the heart-failure drug, levosimendan or Simdax, and another drug, Tricor, which was aimed at further reducing heart problems in diabetics on top of conventional therapy.

FORBES: Magazine Article

Abbott (nyse: ABT - news - people ) shares were down 3.9% in morning trading on mixed results for the heart-failure drug, levosimendan or Simdax, and another drug, Tricor, which was aimed at further reducing heart problems in diabetics on top of conventional therapy.

FORBES: Open Questions For Heart Failure Drugs